Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells

Molecular Cancer Therapeutics

Volumn 4, Issue 2, 2005, Pages 281-290

  Ko, Ching Huai ^a   Shen, Shing Chuan ^b,c   Lee, Tony J F ^d,e   Chen, Yen Chou ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURANTIIN; BAICALEIN; BAICALIN; CATECHIN; FLAVANONE; FLAVONE DERIVATIVE; GELATINASE A; HESPERETIN; HESPERIDIN; INTERSTITIAL COLLAGENASE; KAEMPFEROL; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MORIN; MYRICETIN; NARINGENIN; PROTEIN C JUN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; QUERCETIN; QUERCITRIN; RUTOSIDE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNINDEXED DRUG; WOGONIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL VIABILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; FLAVONOIDS; HUMANS; MATRIX METALLOPROTEINASE 2; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; TETRADECANOYLPHORBOL ACETATE;

EID: 14844321265     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mercapide J, Lopez De Cicco R, Castresana JS, Klein-Szanto AJ. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. Int J Cancer 2003; 106:676-82.
2. Bernardo MM, Fridman R. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J 2003;374:739-45.
3. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003;114: 33-45.
4. Maekawa R, Maki H, Yoshida H, et al. Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Cancer Res 1999;59:1231-5.
5. Rosenblum G, Meroueh SO, Kleifeld O, et al. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2. J Biol Chem 2003;278:27009-15.
6. Shamamian P, Schwartz JD, Pocock BJ, et al. Activation of progelatinase A by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 2001;189:197-206.
7. Bourguignon LY, Gunja-Smith Z, Iida N, et al. CD44v (3, 8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 1998;176:206-15.
8. Ko CH, Shen S-C, Lin H-Y, et al. Flavanones structure related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in antipromotive process. J Cell Physiol 2002;193:93-102.
9. Zeliadt NA, Warmka JK, Winston SE, et al. Tumor promoter-induced MMP-13 gene expression in a model of initiated epidermis. Biochem Biophys Res Commun 2004;317:570-7.
10. Arnott CH, Scott KA, Moore RJ, et al. Tumor necrosis factor-α mediates tumor promotion via a PKC α- and AP-1-dependent pathway. Oncogene 2002;21:4728-38.
11. Hinoda Y, Okayama N, Takano N, et al. Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer 2002;102: 526-9.
12. Chen YC, Shen SC, Lee WR, et al. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol 2002;76:351-9.
13. 2+-dependent endonuclease. Biochem Pharmacol 2002; 63:225-36.
14. Chen YC, Shen SC, Lin HY. Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids. Biochem Pharmacol 2003;66: 1139-50.
15. Shen SC, Chen YC, Hsu FL, Lee WR. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. J Cell Biochem 2003;89:1044-55.
16. Shen SC, Ko CH, Hsu KC, Chen YC. 3-OH flavone inhibition of epidermal growth factor-induced proliferation through blocking prostaglandin E2 production. Int J Cancer 2004;108:502-10.
17. Fishman DA, Liu Y, Ellerbroek SM, Stack MS. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res 2001; 61:3194-9.
18. Huang YT, Hwang JJ, Lee LT, et al. Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells. Int J Cancer 2002;99: 505-13.
19. Shen SC, Ko CH, Tsang SW, Tsai SH, Chen YC. Structurally-related anti-tumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression and reactive oxygen species production. Toxicol Appl Pharmacol 2004;197:84-95.
20. Ko CH, Shen SC, Chen YC. Hydroxylation at C4′ or C6 is essential for apoptosis-inducing activity of flavanone through activation of the caspase 3 cascade and production of reactive oxygen species. Free Radic Biol Med 2004;36:897-910.
21. Lin HY, Uan SH, Shen SC, Hsu FL, Chen YC. Inhibition of lipopolysaccharide-induced nitric oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1. Biochem Pharmacol 2003;66:1821-32.
22. Arora A, Nair MG, Strasburg GM. Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med 1998;24:1355-63.
23. Fiorani M, De Sanctis R, De Bellis R, Dachà M. Intracellular flavonoids as electron donors for extracellular ferricyanide reduction in human erythrocytes. Free Radic Biol Med 2002;32:64-72.
24. Wang H, Joseph JA. Structure-activity relationships of quercetin in antagonizing hydrogen peroxide-induced calcium dysregulation in PC12 cells. Free Radic Biol Med 1999;27:683-94.
25. Cos P, Ying L, Calomme M, et al. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 1998;61:71-6.
26. Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 1997; 22:749-60.
27. Huen Michael-SY, Hui KM, Leung Justin-WC, et al. Naturally occurring 20-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands. Biochem Pharmacol 2003;66:2397-407.
28. Fahrmann M, Kaufhold M, Rieg T, Seidler U. Different actions of protein kinase C isoforms α and epsilon on gastric acid secretion. Br J Pharmacol 2002;136:938-46.
29. Hess A, Wijayanti N, Neuschafer-Rube AP, Katz N, Kietzmann T, Immenschuh S. Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. J Biol Chem 2003;278:45419-34.
30. Hah N, Lee ST. An absolute role of the PKC-dependent NF-κB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2003;305:428-33.
31. Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 2001;91:822-32.
32. Woo JH, Lim JH, Kim YH, et al. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction. Oncogene 2004; 23:1845-53.
33. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003; 24:1269-79.
34. Mira L, Fernandez MT, Santos M, Roche R, Florencio MH, Jennings KR. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 2002;36:1199-208.
35. Fernandez MT, Mira ML, Florencio MH, Jennings KR. Iron and copper chelation by flavonoids: an electrospray mass spectrometry study. J Inorg Biochem 2002;92:105-11.